FDA approves migraine nasal spray

被引：0

|

作者：

不详

机构：

来源：

NURSE PRACTITIONER | 2023年 / 48卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

引用

收藏

页码：48 / 48

页数：1

相关论文

共 50 条

[31] FDA approves pertuzumab
Cormac Sheridan
Nature Biotechnology, 2012, 30 (7) : 570 - 570
[32] FDA approves neotame
不详
FOOD TECHNOLOGY, 2002, 56 (08) : 12 - 12
[33] FDA approves Xenical®
不详
DIABETES-METABOLISM RESEARCH AND REVIEWS, 1999, 15 (04) : 301 - 301
[34] FDA APPROVES AZT
不详
SCIENCE, 1987, 235 (4796) : 1570 - 1570
[35] FDA Approves Zyclara™
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (06) : 723 - 723
[36] FDA approves inhaler
不详
JOURNAL OF EQUINE VETERINARY SCIENCE, 2002, 22 (02) : 69 - 69
[37] DIHYDROERGOTAMINE NASAL SPRAY IN THE ACUTE TREATMENT OF MIGRAINE HEADACHE
MONDELL, B
DISERIO, F
FRIEDMAN, A
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 161 - 161
[38] Parental satisfaction with sumatriptan nasal spray in childhood migraine
Pakalnis, A
Kring, D
Paolicchi, J
JOURNAL OF CHILD NEUROLOGY, 2003, 18 (11) : 772 - 775
[39] Efficacy of zolmitriptan nasal spray in management of acute migraine
Bhattacharyya, Ramesh
Laha, Debal
Gangopadhyay, P. K.
ANNALS OF NEUROSCIENCES, 2012, 19 (01) : 25 - 26
[40] Migraine therapy - Sumatriptan nasal spray effective in children
Christoph, H
PSYCHOPHARMAKOTHERAPIE, 2005, 12 (01): : 34 - 34

← 1 2 3 4 5 →